{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:30:08Z","timestamp":1787772608445,"version":"build-2784847793"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>The purpose was to study the demographics, clinical and radiological presenting patterns, prognostic variables, and outcome of management of rhino-orbital-cerebral-mucormycosis (ROCM) in coronavirus disease (COVID-19) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We retrospectively analyzed COVID-19 patients with proven ROCM from April 2021 to November 2021. All included patients were given systemic antifungal therapy depending on clinical response and underwent functional endoscopic sinus surgery (FESS) with orbital wall decompression. Administration of transcutaneous retrobulbar amphotericin B (TRAMB) injection, exenteration, and maxillectomy was done when indicated as per a novel algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 64 patients with ROCM were included in the study. The mean age of 54.5 (standard deviation [SD] - 10.6) years with a male predominance (male: female = 55:9) was observed. Pre-existing diabetes mellitus (DM) was the most common comorbid state, 47 (73.4%). The most common ophthalmic presentation was proptosis (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 40) (62.5%). Bulky extraocular muscles (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 64) (100%) and intraorbital fat stranding (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 41) (64%) were the most common radiological findings. Twenty-eight patients received TRAMB, while 11 patients underwent exenteration with FESS. Our study had a mortality rate of 18.7% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 12). The mean glycated hemoglobin of 13.5% (SD - 1.1) and a higher serum ferritin value of 976.25 (SD - 592) were observed in the deceased group. Vision was preserved in 38 (73.7%) patients in the survived group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>ROCM has a wide array of presentations, with proptosis as the most common clinical finding. Bulky EOM and intraorbital fat stranding were the most common radiological findings. Thorough surgical debridement with systemic and local antifungal therapy results in reasonable outcomes for ROCM in COVID-19 patients. Older age, intensive care unit admissions, uncontrolled DM, central nervous system involvement, and shorter duration of antifungal treatment are poor prognostic factors associated with mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjopt.sjopt_155_22","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T07:09:37Z","timestamp":1725001777000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical profile, prognostic factors, and outcomes of rhino-orbital-cerebral mucormycosis in the setting of COVID-19: A retrospective study"],"prefix":"10.4103","volume":"37","author":[{"given":"Swetha M.","family":"Hanumappa","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, PSGIMSR, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Karuppannasamy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, PSGIMSR, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1076\/orbi.17.4.237.2742","article-title":"Rhino-orbital-cerebral mucormycosis:A review","volume":"17","author":"Warwar","year":"1998","journal-title":"Orbit"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India:Experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad Med J"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis:An initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code Mucor:Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/QCO.0b013e32834ab21e","article-title":"The emerging epidemiology of mould infections in developing countries","volume":"24","author":"Chakrabarti","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s11033-021-07085-3","article-title":"Resolving the equation between mucormycosis and COVID-19 disease","volume":"49","author":"Pasrija","year":"2022","journal-title":"Mol Biol Rep"},{"issue":"Suppl 5","key":"R9-20240830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1469-0691.2009.02974.x","article-title":"Clinical presentation of zygomycosis","volume":"15","author":"Mantadakis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India:Epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2019","journal-title":"Med Mycol"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.2147\/OPTH.S324977","article-title":"Rhino-orbito-cerebral-mucormycosis during the COVID-19 second wave in 2021 \u2013A preliminary report from a single hospital","volume":"15","author":"Arora","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India \u2013Collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10384-021-00845-5","article-title":"Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations","volume":"65","author":"Bayram","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12070-019-01774-z","article-title":"Rhino-orbital-cerebral mucormycosis:Battle with the deadly enemy","volume":"72","author":"Gupta","year":"2020","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"R15-20240830","first-page":"504","article-title":"Mucormycosis in COVID-19:A systematic review of literature","volume":"29","author":"Nagalli","year":"2021","journal-title":"Infez Med"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3343\/alm.2013.33.6.393","article-title":"HbA1c:A review of analytical and clinical aspects","volume":"33","author":"Weykamp","year":"2013","journal-title":"Ann Lab Med"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/myc.13334","article-title":"Mucormycosis in patients with COVID-19:A cross-sectional descriptive multicentre study from Iran","volume":"64","author":"Pakdel","year":"2021","journal-title":"Mycoses"},{"key":"R18-20240830","first-page":"11","article-title":"Affiliations. Study of hba1c and serum ferritin levels in COVID19 associated mucor mycosis","volume":"70","author":"Maddimani","year":"2022","journal-title":"J Assoc Physicians India 2022"},{"key":"R19-20240830","first-page":"e20569","article-title":"Hyperferritinemia and the extent of mucormycosis in COVID-19 patients","volume":"13","author":"Bhadania","year":"2021","journal-title":"Cureus"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19:We should be prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J Mycol Med"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(05)80041-4","article-title":"Survival factors in rhino-orbital-cerebral mucormycosis","volume":"39","author":"Yohai","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/ICU.0000000000000394","article-title":"Invasive fungal sinusitis:Treatment of the orbit","volume":"28","author":"Kalin-Hajdu","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"R24-20240830","first-page":"40","article-title":"Retrobulbar amphotericin B in mucormycosis\u202f:A ray of hope","volume":"32","author":"Mohan","year":"2022"},{"key":"R25-20240830","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5858\/2001-125-0375-HFOZ","article-title":"Histologic features of zygomycosis:Emphasis on perineural invasion and fungal morphology","volume":"125","author":"Frater","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis:A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/lary.23912","article-title":"Survival outcomes in acute invasive fungal sinusitis:A systematic review and quantitative synthesis of published evidence","volume":"123","author":"Turner","year":"2013","journal-title":"Laryngoscope"},{"key":"R28-20240830","first-page":"2537","article-title":"COVID-19-associated rhino-orbital- cerebral mixed mycoses with intracranial fungal granuloma \u2013An aggressively managed rare entity Access","volume":"69","author":"Sahu","year":"2021","journal-title":"Indian J Ophthalmol 2021 692537-9"},{"key":"R29-20240830","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis:An updated systematic review of literature","volume":"64","author":"Pal","year":"2021","journal-title":"Mycoses"},{"key":"R30-20240830","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/ijp.ijp_839_21","article-title":"COVID-19-associated rhino-orbital cerebral mucormycosis:A systematic review, meta-analysis, and meta-regression analysis","volume":"53","author":"Bhattacharyya","year":"2021","journal-title":"Indian J Pharmacol"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_155_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:05:47Z","timestamp":1787771147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_155_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/sjopt.sjopt_155_22","relation":{},"ISSN":["1319-4534","2542-6680"],"issn-type":[{"value":"1319-4534","type":"print"},{"value":"2542-6680","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"2022-09-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}